# Alendronate

## Binosto effervescent 70mg

| TAH Drug Code      | [OBIN](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OBIN)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment of osteoporosis in postmenopausal women. Treatment to increase bone mass in men with osteoporosis.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Dosing             | 1 tablet once weekly.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Contraindications  | ■ Abnormalities of the esophagus which delay emptying such as stricture or achalasia ■ Inability to stand/sit upright for at least 30 minutes ■ Increased risk of aspiration ■ Hypocalcemia ■ Hypersensitivity to any component of this product                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Adverse Effects    | Common ■ Gastrointestinal: Abdominal pain (2.1% to 6.6% ), Constipation (0.3% to 3.1% ), Diarrhea (0.6% to 3.1% ), Flatulence (2.6% to 4.1% ), Indigestion (1.7% to 3.6% ), Vomiting (pediatric patients, 29.4% ) ■ Neurologic: Headache (2.6% ) ■ Other: Fever (24% ), Influenza-like symptoms Serious ■ Gastrointestinal: Duodenal ulcer disease, Esophageal erosions, Esophageal perforation, Esophageal stricture, Esophagitis (1.5% ), Gastric ulcer (up to 13.2% ), Ulcerative pharyngitis, acute, Ulcer of esophagus (1.5% ) ■ Immunologic: Hypersensitivity reaction ■ Musculoskeletal: Arthralgia, Aseptic necrosis of bone of jaw (0.017% to 0.03% ), Bone pain, Myalgia |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |

